These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7084814)

  • 21. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents.
    Ten Boekel E; Böck M; Vrielink GJ; Liem R; Hendriks H; de Kieviet W
    Thromb Res; 2007; 121(3):361-7. PubMed ID: 17568658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of increased partial thromboplastin time].
    Boneu B
    Rev Prat; 1991 Apr; 41(10):939-40. PubMed ID: 2042002
    [No Abstract]   [Full Text] [Related]  

  • 23. Rabbit (to replace human) brain material in anticoagulant control.
    Lancet; 1986 Jun; 1(8493):1334-5. PubMed ID: 2872464
    [No Abstract]   [Full Text] [Related]  

  • 24. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
    Brandt JT; Triplett DA; Musgrave K; Orr C
    Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Coagulation tests].
    Rasi V
    Duodecim; 1997; 113(13):1263-70. PubMed ID: 10622131
    [No Abstract]   [Full Text] [Related]  

  • 26. [A lyophilized reagent for standardization of the activated partial thromboplastin time].
    Tarasova LN; Platonova GK; Starkova EV; Savinykh EIu
    Lab Delo; 1990; (6):29-32. PubMed ID: 1699033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of prothrombin time reagent (Thromborel) and activated partial thromboplastin time reagent (Pathromtin) from human placenta with those from rabbit brain in laboratory practice (author's transl)].
    Matsuoka M; Kobayashi I; Ito M; Sakuragawa N; Jimbo C; Hattori A; Watanabe T; Takahashi K; Hoshiyama M; Iizumi T; Sanada M; Ashizawa T; Takahashi H; Honda H; Shinada S
    Rinsho Ketsueki; 1978 Jan; 19(1):22-30. PubMed ID: 564980
    [No Abstract]   [Full Text] [Related]  

  • 29. Value of the activated partial thromboplastin time for preoperative detection of coagulation disorders not revealed by a specific questionnaire.
    Janvier G; Winnock S; Freyburger G
    Anesthesiology; 1991 Nov; 75(5):920-1. PubMed ID: 1952225
    [No Abstract]   [Full Text] [Related]  

  • 30. Mixing studies for abnormal coagulation screen - the current trend.
    Mohammad E; Thachil J
    Clin Chem Lab Med; 2017 Mar; 55(3):e54-e55. PubMed ID: 27522100
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clotting time and kaolin clotting time].
    Amagai H; Murakami M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():581-3. PubMed ID: 15658394
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prolonged activated partial thromboplastin time, Quick's time, bleeding time. Diagnostic orientation].
    Guillin MC
    Rev Prat; 1994 Sep; 44(14):1942-8. PubMed ID: 7939287
    [No Abstract]   [Full Text] [Related]  

  • 34. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
    Bowyer A; Smith J; Woolley AM; Kitchen S; Hampton KK; Maclean RM; VAN Veen JJ; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 36. Mixing Study for Evaluation of Abnormal Coagulation Testing.
    Choi SH; Rambally S; Shen YM
    JAMA; 2016 Nov; 316(20):2146-2147. PubMed ID: 27893111
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnostic of blood coagulation].
    Barthels M
    Hamostaseologie; 2008 Dec; 28(5):320-34. PubMed ID: 19132163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. False prolongation of the activated partial thromboplastin time (aPTT) in inflammatory patients: interference of C-reactive protein.
    van Rossum AP; Vlasveld LT; van den Hoven LJ; de Wit CW; Castel A
    Br J Haematol; 2012 May; 157(3):394-5. PubMed ID: 22224499
    [No Abstract]   [Full Text] [Related]  

  • 39. Coagulation disorders in massively injured patients.
    Harke H; Rahman S
    Prog Clin Biol Res; 1982; 108():213-24. PubMed ID: 6817337
    [No Abstract]   [Full Text] [Related]  

  • 40. A novel spray reagent for phospholipid detection.
    Kundu SK; Chakravarty S; Bhaduri N; Saha HK
    J Lipid Res; 1977 Jan; 18(1):128-30. PubMed ID: 833504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.